Global Blood Banking and Blood Products Market Strategic Research Report

Scope of the Report

The global Blood Banking and Blood Products market size is predicted to grow from US$ 62,730 million in 2025 to US$ 99,460 million in 2032; it is expected to grow at a CAGR of 6.9% from 2026 to 2032.

Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine.

Blood products refer to various human plasma protein products, including albumin, immunoglobulin, coagulation factors, etc. The raw material of blood products is plasma. 92% - 93% of human plasma is water, and only 7% - 8% is protein. Blood products are made by separating and purifying this part of protein.

The primary driver of the blood banking market is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Conditions such as cancer, anemia, and trauma often require blood transfusions, boosting the demand for blood and blood products. Additionally, advancements in medical technology, such as improved blood preservation techniques and the development of blood substitutes, have enhanced the efficiency of blood banking systems, further contributing to market growth. One major challenge in the blood banking market is the risk of blood contamination and the transmission of infectious diseases. Despite stringent screening processes, there remains a possibility of contamination, especially in regions with less advanced healthcare systems. Furthermore, the high cost of blood testing and the maintenance of blood banks, coupled with the difficulty in ensuring a consistent blood supply due to low donation rates in some areas, presents significant obstacles to market expansion.

The growing prevalence of immunodeficiency disorders, hemophilia, and other chronic diseases that require plasma-derived therapies is a key driver of the blood product market. Blood products, such as immunoglobulins, clotting factors, and albumin, are essential in treating conditions where patients have compromised immune systems or bleeding disorders. Furthermore, the increasing use of plasma products in emergency care and surgical procedures, along with advancements in fractionation technologies, is boosting market demand. A major challenge in the blood product market is the high cost and complexity of the plasma collection and fractionation process. The production of blood products requires strict regulatory compliance and advanced facilities to ensure the purity and safety of these therapies, driving up costs. Additionally, fluctuations in plasma donation rates and the need for extensive screening to prevent contamination or the spread of infectious diseases can lead to supply shortages, especially in regions with underdeveloped healthcare infrastructure.

This report presents a comprehensive overview of the global Blood Banking and Blood Products market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• RBCs
• Plts
• Plasma
• Whole Blood
• Plasma Fractionation Products

Segment by players, this report covers

• America’s Blood Centers
• Japan Red Cross Society
• American Red Cross
• Australia Red Cross
• Red Cross Society of China
• NHS Blood and Transplant
• New York Blood Center
• Canadian Blood Services
• Sanquin Blood Supply Foundation
• Blood Bank of Alaska
• Vitalant
• National Blood Transfusion Council
• Takeda
• CSL
• Grifols
• Octapharma
• Kedrion
• LFB Group
• Biotest
• BPL
• RAAS
• CBPO
• Hualan Bio
• Tiantan Bio
• Shuanglin Bio
• Boya Bio
• Yuanda Shuyang
• Weiguang Bio
• Nanyue Bio
• KM Biologics

Segment by Application

• Hospital
• Clinic
• Retail Pharmacy
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blood Banking and Blood Products market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Retail Pharmacy evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact